MRO
40
-15
URI
60
7
CINF
51
4
LEN
52
2
BK
72
4
CMS
60
2
GIS
28
2
HSIC
51
-3
STI
31
-16
L
64
2
PFG
42
3
NTAP
66
2
JNJ
44
3
KMX
64
6
FITB
60
2
BIIB
28
2
XRX
41
6
BA
49
-3
ROST
52
5
FDX
40
4
MRO
40
-15
URI
60
7
CINF
51
4
LEN
52
2
BK
72
4
CMS
60
2
GIS
28
2
HSIC
51
-3
STI
31
-16
L
64
2
PFG
42
3
NTAP
66
2
JNJ
44
3
KMX
64
6
FITB
60
2
BIIB
28
2
XRX
41
6
BA
49
-3
ROST
52
5
FDX
40
4
Financhill
Back

Corcept Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
78

CORT
Corcept Therapeutics

Last Price:
57.51
Seasonality Move:
2.29%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Corcept Therapeutics Price Quote

$57.51
-0.03 (2.84%)
(Updated: November 23, 2024 at 2:32 AM ET)

Corcept Therapeutics Key Stats

Buy
78
Corcept Therapeutics (CORT) is a Buy
Day range:
$56.14 - $57.71
52-week range:
$20.84 - $61.66
Dividend yield:
0%
P/E ratio:
61.21
P/S ratio:
10.20
P/B ratio:
9.44%
Volume:
671K
Avg. volume:
1.1M
1-year change:
127.07%
Market cap:
$6B
Revenue:
$482.4M
EPS:
$1.26

How Much Does Corcept Therapeutics Make?

Is Corcept Therapeutics Growing As A Company?

  • What Is Corcept Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.48%
  • What Is Corcept Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.46%

Corcept Therapeutics Stock Price Performance

What Is Corcept Therapeutics 52-Week High & Low?

Corcept Therapeutics Price To Free Cash Flow

Is It Risky To Buy Corcept Therapeutics?

Is Corcept Therapeutics Cash Flow Positive?

  • What Is CORT Cash Flow From Operations?
    Cash flow from operations (TTM) is $144.7M
  • What Is Corcept Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$23M
  • What Is Corcept Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$96.1M

Corcept Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    CORT return on invested capital is 25.77%
  • What Is Corcept Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 21.04%
  • What Is CORT Return On Equity?
    ROE is a measure of profitability and is 25.77%

Corcept Therapeutics Earnings Date & Stock Price

Corcept Therapeutics Competitors

  • Who Are Corcept Therapeutics's Competitors?
    Below is a list of companies who compete with Corcept Therapeutics or are related in some way:
    • ADMA Biologics Inc (ADMA)
    • Alnylam Pharmaceuticals Inc (ALNY)
    • Catalyst Pharmaceuticals Inc (CPRX)
    • Madrigal Pharmaceuticals Inc (MDGL)
    • Merit Medical Systems Inc (MMSI)

Corcept Therapeutics Dividend Yield

Corcept Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 46.43% 41.38%
Revenue: 47.69% 6.15%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 74.90
Upside from Last Price: 30.17%

Major Shareholders

  • How many CORT shares are owned by institutional investors?
    131.6M CORT shares are owned by institutional investors
  • How many CORT shares are owned by insiders?
    8.5M CORT shares are owned by insiders